Tesamorelin – Growth Hormone Releasing Hormone (GHRH) Analog for Metabolic Research
Tesamorelin is a synthetic GHRH analog widely studied in endocrine and metabolic research for its ability to stimulate endogenous growth hormone (GH) release via activation of growth hormone–releasing hormone receptors. This peptide has drawn significant scientific interest in studies examining visceral adipose tissue, body composition, and hormone-regulated metabolic pathways.
In controlled clinical settings, Tesamorelin has been investigated for its effects on reducing visceral fat accumulation, particularly in models associated with lipodystrophy and altered fat distribution. These findings have positioned Tesamorelin as a valuable compound for laboratory research focused on metabolic health, adipose tissue regulation, and growth hormone physiology.
Researchers frequently utilize Tesamorelin in studies exploring:
- Growth hormone secretion and endocrine signaling
- Visceral adipose tissue and fat metabolism models
- Body composition and metabolic regulation research
- Hormone-mediated pathways involved in lipodystrophy
Tesamorelin’s well-characterized interaction with GHRH receptors makes it a preferred peptide for investigations into GH axis modulation and related metabolic outcomes.
For laboratory research use only. Not for human consumption.
